Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statistical data processing in clinical proteomics.

Suzanne Smit1, Huub C J Hoefsloot, Age K Smilde

  • 1Swammerdam Institute for Life Sciences, Universiteit van Amsterdam - Nieuwe Achtergracht 166, 1018 WV Amsterdam, The Netherlands. ssmit@science.uva.nl

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|November 24, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of microbiome high-dimensional experimental design data using generalized linear models and ANOVA simultaneous component analysis.

Frontiers in microbiomes·2026
Same author

ACMTF-R: Supervised multi-omics data integration uncovering shared and distinct outcome-associated variation.

PloS one·2026
Same author

Improved epigenetic age prediction models by combining sex chromosome and autosomal markers.

Epigenetics & chromatin·2025
Same author

Prioritization strategies for non-target screening in environmental samples by chromatography - High-resolution mass spectrometry: A tutorial.

Journal of chromatography. A·2025
Same author

Longitudinal Metabolomics Data Analysis Informed by Mechanistic Models.

Metabolites·2025
Same author

Parameter Dependency of Electrochemical Reduction of CO<sub>2</sub> in Acetonitrile - A Data Driven Approach.

Chemphyschem : a European journal of chemical physics and physical chemistry·2024
Same journal

Integrated network pharmacology, gut microbiome, and metabolomics analyses reveal the protective mechanism of Guizhi Gegen decoction against influenza.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
Same journal

Identification of 11α/β-hydroxy-12β-deoxysaxitoxin (12β-deoxyM2) in bivalve molluscs.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
Same journal

High-resolution LC-MS/MS analysis of brain N-glycans reveals composition-specific changes in Parkinson's disease.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
Same journal

The discovery of α-glucosidase inhibitors from Folium Mori using virtual screening and ligand fishing strategies.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
Same journal

Matrix fidelity in microsampling: Plasma-first LC-MS/MS quantification of mycophenolic acid and MPAG.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
Same journal

Rapid two-step purification of Podoviridae bacteriophages using CIMmultus monolithic chromatography.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
See all related articles

This review outlines data analysis strategies for biomarker discovery in clinical proteomics. It emphasizes robust statistical validation, including cross-validation and permutation testing, for reliable biomarker identification.

Area of Science:

  • Proteomics
  • Biomarker Discovery
  • Clinical Research

Background:

  • Clinical proteomics studies generate high-dimensional data with limited samples.
  • Numerous classification methods exist, but effective feature selection and validation are critical.
  • Current practices often lack rigorous statistical validation for biomarker leads.

Purpose of the Study:

  • To review data analysis strategies for biomarker discovery in clinical proteomics.
  • To highlight the importance of statistical validation for developing generalized classifiers.
  • To present a modular framework for feature selection, classification, biomarker discovery, and validation.

Main Methods:

  • Discussion of various feature selection techniques for dimensionality reduction.

Related Experiment Videos

  • Overview of classification strategies for biomarker identification.
  • Emphasis on statistical validation methods, including cross-validation and permutation testing.

    • Main Results:

    • No single classification strategy is universally superior; method selection is researcher-dependent.
    • Validated model selection is essential for developing generalized classifiers.
    • A modular framework integrating feature selection, classification, and validation is proposed.

    Conclusions:

    • Robust statistical validation, combining cross-validation and permutation testing, is crucial for biomarker discovery.
    • The proposed modular framework allows flexibility in analysis while mandating validation.
    • Rigorous validation ensures the reliability of biomarker leads for clinical application.